10-119425003-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005308.3(GRK5):āc.451G>Cā(p.Glu151Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000072 in 1,611,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005308.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRK5 | NM_005308.3 | c.451G>C | p.Glu151Gln | missense_variant | 6/16 | ENST00000392870.3 | NP_005299.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRK5 | ENST00000392870.3 | c.451G>C | p.Glu151Gln | missense_variant | 6/16 | 1 | NM_005308.3 | ENSP00000376609 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000316 AC: 48AN: 152062Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251480Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135910
GnomAD4 exome AF: 0.0000466 AC: 68AN: 1459180Hom.: 0 Cov.: 29 AF XY: 0.0000413 AC XY: 30AN XY: 726120
GnomAD4 genome AF: 0.000315 AC: 48AN: 152180Hom.: 0 Cov.: 31 AF XY: 0.000336 AC XY: 25AN XY: 74398
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.451G>C (p.E151Q) alteration is located in exon 6 (coding exon 6) of the GRK5 gene. This alteration results from a G to C substitution at nucleotide position 451, causing the glutamic acid (E) at amino acid position 151 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at